When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Researchers from the Tata Memorial Centre (TMC), Mumbai, and the National Institute of Biomedical Genomics (NIBMG) in West Bengal on Wednesday claimed to have found key genomic factors that contribute ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

She began attending the clinic in November 2024 and has noticed improvements in the way she feels. Hers is a complex case of menopause because of her medical history. It has been four years since ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...